PT Kalbe Farma Tbk. Statistics

Total Valuation

FRA:LCLA has a market cap or net worth of EUR 2.71 billion. The enterprise value is 2.61 billion.

Market Cap	2.71B
Enterprise Value	2.61B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	45.32B
Shares Outstanding	n/a
Shares Change (YoY)	-1.15%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.35%
Owned by Institutions (%)	10.97%
Float	18.08B

Valuation Ratios

The trailing PE ratio is 15.17 and the forward PE ratio is 13.90.

PE Ratio	15.17
Forward PE	13.90
PS Ratio	1.54
PB Ratio	2.14
P/TBV Ratio	2.56
P/FCF Ratio	19.67
P/OCF Ratio	15.43
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.68, with an EV/FCF ratio of 18.98.

EV / Earnings	14.63
EV / Sales	1.48
EV / EBITDA	9.68
EV / EBIT	11.39
EV / FCF	18.98

Financial Position

The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.02.

Current Ratio	3.85
Quick Ratio	2.15
Debt / Equity	0.02
Debt / EBITDA	0.10
Debt / FCF	0.19
Interest Coverage	97.94

Financial Efficiency

Return on equity (ROE) is 14.55% and return on invested capital (ROIC) is 10.99%.

Return on Equity (ROE)	14.55%
Return on Assets (ROA)	9.33%
Return on Invested Capital (ROIC)	10.99%
Return on Capital Employed (ROCE)	17.27%
Revenue Per Employee	137,313
Profits Per Employee	13,954
Employee Count	12,903
Asset Turnover	1.17
Inventory Turnover	2.99

Taxes

In the past 12 months, FRA:LCLA has paid 56.41 million in taxes.

Income Tax	56.41M
Effective Tax Rate	23.76%

Stock Price Statistics

The stock price has decreased by -31.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.48%
50-Day Moving Average	0.06
200-Day Moving Average	0.06
Relative Strength Index (RSI)	42.57
Average Volume (20 Days)	300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:LCLA had revenue of EUR 1.76 billion and earned 178.39 million in profits. Earnings per share was 0.00.

Revenue	1.76B
Gross Profit	700.82M
Operating Income	224.28M
Pretax Income	237.43M
Net Income	178.39M
EBITDA	262.60M
EBIT	224.28M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 214.48 million in cash and 26.62 million in debt, giving a net cash position of 187.85 million.

Cash & Cash Equivalents	214.48M
Total Debt	26.62M
Net Cash	187.85M
Net Cash Per Share	n/a
Equity (Book Value)	1.27B
Book Value Per Share	0.03
Working Capital	680.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 175.40 million and capital expenditures -37.85 million, giving a free cash flow of 137.56 million.

Operating Cash Flow	175.40M
Capital Expenditures	-37.85M
Free Cash Flow	137.56M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 39.92%, with operating and profit margins of 12.78% and 10.16%.

Gross Margin	39.92%
Operating Margin	12.78%
Pretax Margin	13.53%
Profit Margin	10.16%
EBITDA Margin	14.96%
EBIT Margin	12.78%
FCF Margin	7.84%

Dividends & Yields

This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 3.50%.

Dividend Per Share	0.00
Dividend Yield	3.50%
Dividend Growth (YoY)	-99.99%
Years of Dividend Growth	3
Payout Ratio	46.82%
Buyback Yield	1.15%
Shareholder Yield	4.64%
Earnings Yield	6.59%
FCF Yield	5.08%

Dividend Details

Stock Splits

The last stock split was on October 8, 2012. It was a forward split with a ratio of 5.

Last Split Date	Oct 8, 2012
Split Type	Forward
Split Ratio	5

Scores

FRA:LCLA has an Altman Z-Score of 10.44 and a Piotroski F-Score of 6.

Altman Z-Score	10.44
Piotroski F-Score	6